Are you Looking to Buy Azilect (Rasagiline) from PrescriptionPoint.

Azilect (rasagiline)

Indications

• Azilect is prescribed for the treatment of Parkinson’s disease.
• It helps improve motor symptoms such as tremors, stiffness, and slowness of movement.

Dosage and Administration:

• Follow your doctor’s prescribed dosage and schedule for Azilect intake.
• Swallow the tablets whole with or without food, as directed by your doctor.
• Inform your doctor of any other medications you are taking to avoid potential interactions.
• Do not stop taking Azilect suddenly without consulting your doctor.

Mechanism of Action

Azilect contains rasagiline, a monoamine oxidase inhibitor (MAOI). It works by increasing levels of dopamine, a neurotransmitter in the brain that helps control movement and coordination, thus alleviating Parkinson’s symptoms.

Contraindications

• Do not take Azilect if you are allergic to rasagiline or any other MAOI.
• Avoid Azilect if you are currently taking or have recently taken certain antidepressants, including SSRIs and TCAs, without consulting your doctor.
• Consult your doctor before using Azilect if you have severe liver disease.

Side Effects

Common Side Effects

• Headache
• Dizziness
• Nausea
• Dry mouth
• Joint pain

Serious Side Effects

• Hallucinations
• Severe headache
• Chest pain
• Irregular heartbeat
• Difficulty breathing

Precautions

• Inform your doctor about your medical history, especially if you have liver problems or a history of mental/mood disorders.
• Be cautious when driving or operating machinery, as Azilect may cause dizziness or drowsiness.
• Avoid consuming foods or drinks containing tyramine, as this can lead to a dangerous increase in blood pressure.
• Report any unusual symptoms or side effects to your doctor promptly.

Storage Instructions

• Store Azilect tablets at room temperature (15°C to 30°C) in a tightly closed container, away from moisture and light.
• Keep out of reach of children and pets.
• Do not use after the expiration date.

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021641s016s017lbl.pdf